151 related articles for article (PubMed ID: 10553856)
1. An intrasubject comparison of two doses of succinylcholine in modified electroconvulsive therapy.
Murali N; Saravanan ES; Ramesh VJ; Gangadhar BN; Jananakiramiah N; Kumar SS; Christopher R; Subbakrishna DK
Anesth Analg; 1999 Nov; 89(5):1301-4. PubMed ID: 10553856
[TBL] [Abstract][Full Text] [Related]
2. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy.
Cheam EW; Critchley LA; Chui PT; Yap JC; Ha VW
Can J Anaesth; 1999 Jan; 46(1):49-51. PubMed ID: 10078403
[TBL] [Abstract][Full Text] [Related]
3. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
Mirzakhani H; Guchelaar HJ; Welch CA; Cusin C; Doran ME; MacDonald TO; Bittner EA; Eikermann M; Nozari A
Anesth Analg; 2016 Sep; 123(3):587-96. PubMed ID: 26967896
[TBL] [Abstract][Full Text] [Related]
4. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT.
Akcaboy ZN; Akcaboy EY; Yigitbasł B; Bayam G; Dikmen B; Gogus N; Dilbaz N
Acta Anaesthesiol Scand; 2005 Sep; 49(8):1068-71. PubMed ID: 16095445
[TBL] [Abstract][Full Text] [Related]
5. Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal.
Bryson EO; Aloysi AS; Popeo DM; Bodian CA; Pasculli RM; Briggs MC; Kellner CH
J ECT; 2012 Sep; 28(3):e29-30. PubMed ID: 22914634
[TBL] [Abstract][Full Text] [Related]
6. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine.
Turkkal DC; Gokmen N; Yildiz A; Iyilikci L; Gokel E; Sagduyu K; Gunerli A
J Clin Anesth; 2008 Dec; 20(8):589-93. PubMed ID: 19100931
[TBL] [Abstract][Full Text] [Related]
7. Correlates of myalgia in electroconvulsive therapy.
Rasmussen KG; Petersen KN; Sticka JL; Wieme LJ; Zosel JH; Marienau ME; Ryan DA; Schroeder DR; Stevens SR; Hooten WM; Spackman TN
J ECT; 2008 Mar; 24(1):84-7. PubMed ID: 18379340
[TBL] [Abstract][Full Text] [Related]
8. [Anesthesia for electroconvulsive therapy: clinical experience].
González AG; Cortínez LI; De la Cuadra JC; Carrasco E; Rioseco A; Léniz P
Rev Esp Anestesiol Reanim; 2007; 54(7):414-20. PubMed ID: 17953335
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine blunts acute hyperdynamic responses to electroconvulsive therapy without altering seizure duration.
Begec Z; Toprak HI; Demirbilek S; Erdil F; Onal D; Ersoy MO
Acta Anaesthesiol Scand; 2008 Feb; 52(2):302-6. PubMed ID: 17976228
[TBL] [Abstract][Full Text] [Related]
10. Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy.
Bryson EO; Kellner CH; Li EH; Aloysi AS; Majeske M
Australas Psychiatry; 2018 Aug; 26(4):391-393. PubMed ID: 29504412
[TBL] [Abstract][Full Text] [Related]
11. General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman.
Narayanan A; Lal C; Al-Sinawi H
Sultan Qaboos Univ Med J; 2017 Feb; 17(1):e43-e49. PubMed ID: 28417028
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Mollerup HM; Gätke MR
Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
[TBL] [Abstract][Full Text] [Related]
13. A naturalistic comparison of two right unilateral electroconvulsive therapy dosing protocols: 2-3X seizure threshold versus fixed high-dose.
Ward WK; Lush P; Kelly M; Frost AD
Psychiatry Clin Neurosci; 2006 Aug; 60(4):429-33. PubMed ID: 16884443
[TBL] [Abstract][Full Text] [Related]
14. Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
Nomoto K; Suzuki T; Serada K; Oe K; Yoshida T; Yamada S
J Anesth; 2006; 20(3):183-7. PubMed ID: 16897237
[TBL] [Abstract][Full Text] [Related]
15. Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy.
Bryson EO; Aloysi AS; Perez AM; Popeo D; Kellner CH
J ECT; 2011 Mar; 27(1):e42-3. PubMed ID: 21206375
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient.
Hudcova J; Schumann R
Gen Hosp Psychiatry; 2006; 28(5):440-2. PubMed ID: 16950383
[TBL] [Abstract][Full Text] [Related]
17. Interrater reliability of 2 definitions of seizure adequacy in electroconvulsive therapy.
Semple DM; Gunn W; Ellahi R; Queirazza F
J ECT; 2013 Mar; 29(1):21-4. PubMed ID: 23303415
[TBL] [Abstract][Full Text] [Related]
18. The effect of electroconvulsive therapy using propofol and succinylcholine on the intraocular pressure.
Boroojeny SB; Tabatabai NH; Babakhani B; Babakhani S; Moody Z
Middle East J Anaesthesiol; 2012 Jun; 21(5):713-7. PubMed ID: 23265035
[TBL] [Abstract][Full Text] [Related]
19. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression.
White PF; Amos Q; Zhang Y; Stool L; Husain MM; Thornton L; Downing M; McClintock S; Lisanby SH
Anesth Analg; 2006 Jul; 103(1):76-80, table of contents. PubMed ID: 16790630
[TBL] [Abstract][Full Text] [Related]
20. Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy.
Nakano M; Funayama M; Takata T; Wakisaka R; Koyama G; Koreki A; Ishida T; Uchida H; Mimura M
BMC Psychiatry; 2024 Jun; 24(1):411. PubMed ID: 38834964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
